• Entry
  • Reader's guide
  • Entries A-Z
  • Subject index

On July 21, 2004, President George W. Bush signed the Project Bioshield Act (P.L. 108-276) into law. This act provided the government with the authority and funding to develop, purchase, stockpile, and deliver medical countermeasures to U.S. civilians in the event of a chemical, biological, radiological, or nuclear (CBRN) incident or attack. Project Bioshield designated authority to the Secretary of the Health and Human Services (HHS) and agencies within. The act originally authorized $5.6 billion Special Reserve Funds (SRF) to the U.S. Department of Homeland Security over 10 years to acquire the next generation drugs and vaccines to protect civilians against CBRN incidents and attacks. Since 2004, the HHS to create a CBRN medical countermeasure market has utilized approximately $3.3 billion. Under the Project Bioshield ...

    • Loading...
    locked icon

    Sign in to access this content

    Get a 30 day FREE TRIAL

    • Watch videos from a variety of sources bringing classroom topics to life
    • Read modern, diverse business cases
    • Explore hundreds of books and reference titles